e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Allergen immunotherapy and anti-immunoglobulin E
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series)
A. Stanziola, E. Carpentieri, C. Vitale, M. Pitassi, N. Sorrentino, M. Sofia (Naples, Italy)
Source:
Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Session:
Allergen immunotherapy and anti-immunoglobulin E
Session type:
Poster Discussion
Number:
276
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Stanziola, E. Carpentieri, C. Vitale, M. Pitassi, N. Sorrentino, M. Sofia (Naples, Italy). Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series). Eur Respir J 2011; 38: Suppl. 55, 276
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018
Year: 2018
Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001
Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003
Improvement in asthma severity and control by voriconazole and posaconazole in severe asthma with fungal sensitization (SAFS) and ABPA
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010
Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
Source: Eur Respir Rev 2014; 23: 149-152
Year: 2014
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Place of azoles in the treatment of allergic bronchopulmonary candidiasis
Source: Eur Respir J 2006; 28: Suppl. 50, 52s
Year: 2006
Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Bronchopulmonary aspergillosis
Source: Respipedia Article
Year: 2017
Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011
A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Source: Eur Respir J 2016; 47: 490-498
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept